Pharvaris presents deucrictibant long-term extension data for both the prophylactic and on-demand treatment of HAE at the Bradykinin Symposium 2024...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Rubriques :
Maroc - HAEI.ORG - A La Une - 30/Aug 11:26
Astria to present at upcoming Bradykinin Symposium
Astria to present at upcoming Bradykinin Symposium Astra Therapeutics announced that it will present two posters at the upcoming Bradykinin Symposium in Berlin, Germany on 6 September 2024: Chris Morabito, M.D., Chief Medical Officer at Astria Therapeutics, will present information on ALPHA-SOLAR, a long-term open-label trial of navenibart (STAR-0215) in people living with HAE, [...]
Articles similaires
BioCryst presents new Orladeyo (berotralstat) data at 7th Bradykinin Symposium
haei.org - 06/Sep 18:48
BioCryst presents new Orladeyo (berotralstat) data at 7th Bradykinin Symposium BioCryst Pharmaceuticals today announced the presentation of six...
Pharvaris presents data at the Bradykinin Symposium 2024
haei.org - 05/Sep 18:46
Pharvaris presents data at the Bradykinin Symposium 2024 Pharvaris announced a summary of data being presented at the ongoing 7th Bradykinin...
KalVista Presents Sebetralstat Data at Bradykinin Symposium 2024
haei.org - 06/Sep 18:54
KalVista Pharmaceuticals Presents Sebetralstat Data at Bradykinin Symposium 2024 KalVista Pharmaceuticals announced that it presented additional...
Intellia to present data from the Phase 2 study of NTLA-2002 for the treatment of HAE at the 2024 ACAAI Annual Scientific Meeting
haei.org - 12/Sep 13:18
Intellia Therapeutics to present data from the Phase 2 study of NTLA-2002 for the treatment of hereditary angioedema (HAE) at the 2024 ACAAI Annual...
Germany announces tougher border controls
rt.com - 09/Sep 18:29
Berlin will reimpose passport checks along the border, after the ruling coalition lost two state elections to anti-immigration populists Read Full...
Sod turned at upcoming RNA research and manufacturing facility
aumanufacturing.com.au - 09/Sep 03:58
Construction has begun at the RNA Research and Pilot Manufacturing Facility at Macquarie University’s main campus, northwest of Sydney’s CBD, with...
Swiss Textile Machinery Manufacturers On Tour: Innovations To Be Presented At Symposium In Charlotte, N.C.
textileworld.com - 13/Sep 15:12
ZURICH, Switzerland — September 13, 2024 —The Swiss Textile Machinery Association (Swissmem) is presenting special events in key markets...
Les derniers communiqués
-
Aucun élément